- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Flash glucose monitoring may improve diabetes management in Indigenous Australians
Última actualización 18 de julio de 2026
Key finding
No between-group differences were observed for change in HbA1c.
This pilot randomized controlled trial evaluated flash glucose monitoring in Indigenous Australians with type 2 diabetes, finding no significant differences in key outcomes.
Quick read
Study at a glance
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Risk of bias
Some Concerns
Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.
Plain-language summary
What this paper says
A plain-language read of the study’s main message and where it applies.
Study focus
This pilot randomized controlled trial evaluated flash glucose monitoring in Indigenous Australians with type 2 diabetes, finding no significant differences in key outcomes.
Clinical relevance
Understanding the effectiveness of different diabetes management strategies is crucial for improving health outcomes in Indigenous Australians, a group that faces unique health challenges. This study contributes to the ongoing evaluation of technology-based interventions in diabetes care, highlighting the need for tailored approaches that consider cultural and contextual factors.
Keep in mind
Small sample size may limit generalizability. Short duration of the study may not capture long-term effects. Potential unmeasured confounders could influence outcomes.
Published in
Referencia de la Revista
Publication details and source links for this paper.
Audrey SE, Mariam H, Tracey H, et al. Flash glucose monitoring in Indigenous Australians with type 2 diabetes: a pilot randomized controlled trial. Pilot and Feasibility Studies. 2025;11:72. doi:10.1186/s40814-025-01607-7
Efectos Principales
No significant change in HbA1c levels between intervention groups.
No significant difference in percentage of time spent in target blood glucose.
No severe hypoglycaemic episodes occurred in either group.
No significant differences in EQ-5D-3L quality of life scores.
Evidence network
How this study fits
Understand where this research contributes within the broader evidence network.
Evidence Context
This study contributes evidence to Freestyle Libre 1 FGM use, Standard care with capillary blood glucose monitoring and Blood glucose, HbA1c, Number of hypoglycaemic episodes, and 1 more.
This study contributes evidence to
Primary intervention
Freestyle Libre 1 FGM use
Primary outcomes
- Blood glucose
- HbA1c
- Number of hypoglycaemic episodes
Evidence topics
Primary intervention
Primary outcomes
Evidence relationships
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
Why this study matters
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
2
Related topics
8
Evidence pairs
555
Related studies
Why it is useful
- Contributes to 8 evidence relationships
- Includes primary outcome data
- Linked to 2 direct semantic evidence topics
Topic contributions
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Agrega evidencia relacionada a tu Evidence Tracker
Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.
Evidencia principal
Tema de evidencia
Glycemic Control
matched_outcome
Evidencia relacionada
Tema de evidencia
HbA1c Reduction
Guardar evidencia
Core evidence
Study findings
The primary outcomes reported in this study.
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 75
- Positive
- ConsistencyScore™
- 35
- mixed
Number of hypoglycaemic episodes
Freestyle Libre 1 FGM use → Number of hypoglycaemic episodes
Freestyle Libre 1 FGM use → Number of hypoglycaemic episodes
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Quality of life
Freestyle Libre 1 FGM use → Quality of life
Freestyle Libre 1 FGM use → Quality of life
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Blood glucose
Standard care with capillary blood glucose monitoring → Blood glucose
Standard care with capillary blood glucose monitoring → Blood glucose
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 75
- Positive
- ConsistencyScore™
- 35
- mixed
HbA1c
Standard care with capillary blood glucose monitoring → HbA1c
Standard care with capillary blood glucose monitoring → HbA1c
- EvidenceScore™
- Strong
- Score 79 · Based on 3 studies
- ImpactScore™
- 67
- Slightly Positive
- ConsistencyScore™
- 67
- generally_consistent
Number of hypoglycaemic episodes
Standard care with capillary blood glucose monitoring → Number of hypoglycaemic episodes
Standard care with capillary blood glucose monitoring → Number of hypoglycaemic episodes
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Quality of life
Standard care with capillary blood glucose monitoring → Quality of life
Standard care with capillary blood glucose monitoring → Quality of life
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- 100
- consistent
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
La Evidencia Sugiere
- No between-group differences were observed for HbA1c changes.
- Percentage of time spent in target blood glucose was similar across groups.
- Quality of life scores showed no significant differences.
A quién se aplica
- Indigenous Australians with type 2 diabetes.
- Adults aged 18 and older with diabetes management needs.
Tener en Cuenta
- Results may not apply to non-Indigenous populations.
- Findings are based on a pilot study, requiring further research.
- Cultural factors may influence diabetes management effectiveness.
Entre Líneas
- Small sample size may limit generalizability.
- Short duration of the study may not capture long-term effects.
- Potential unmeasured confounders could influence outcomes.
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Connected Evidence
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Standard care with capillary blood glucose monitoring and HbA1c, Freestyle Libre 1 FGM use and HbA1c.
Relaciones de evidencia relacionadas
Explore in Evidence ExplorerThis study contributes to the evidence on the following intervention-outcome relationships.
- EvidenceScore™
- Strong
- Score 79 · Based on 3 studies
- ImpactScore™
- 67
- Slightly Positive
- ConsistencyScore™
- 67
- generally_consistent
Freestyle Libre 1 FGM use → HbA1c
Devices & Technology
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 75
- Positive
- ConsistencyScore™
- 35
- mixed
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- 100
- consistent
Incluido en estas colecciones de evidencia
Curated evidence collections and hubs this study is part of.
HbA1c Evidence Hub
All studies measuring HbA1c
Measures HbA1c as a key outcome.
Standard care with capillary blood glucose monitoring Evidence Hub
All studies on Standard care with capillary blood glucose monitoring
Contributes to Standard care with capillary blood glucose monitoring evidence base.
Freestyle Libre 1 FGM use Evidence Hub
All studies on Freestyle Libre 1 FGM use
Contributes to Freestyle Libre 1 FGM use evidence base.
Quality of Life Outcomes Evidence Hub
All studies measuring Quality of Life Outcomes
Measures Quality of Life Outcomes as a key outcome.
Recent Diabetes Research
Latest published studies
Published within the last 2 years.
Explora más en Evidence Explorer
Jump to pre-filtered views in Evidence Explorer.
All studies on Standard care with capillary blood glucose monitoring and HbA1c
3 results
All studies on Freestyle Libre 1 FGM use and HbA1c
2 results
All studies on Standard care with capillary blood glucose monitoring
3 results
All studies on Freestyle Libre 1 FGM use
2 results
All studies measuring HbA1c
3 results
Questions answered by this study
Generated from the study's connected evidence using Evidence Intelligence™.
Does Standard care with capillary blood glucose monitoring improve HbA1c?
Standard care with capillary blood glucose monitoring may improve HbA1c.
ConsistencyScore™: Results are generally consistent across studies.
Ranked evidence signals
- 1
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 79.0 | weak positive | ConsistencyScore™ Generally Consistent | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Population details are unavailable.
Does Freestyle Libre 1 FGM use improve HbA1c?
Freestyle Libre 1 FGM use may improve HbA1c.
ConsistencyScore™: Results are mixed and should be interpreted cautiously.
Ranked evidence signals
- 1
HbA1c
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 1 study
Why this answer: This answer is cautious because the available studies report mixed findings.
Limitations
- Only one supporting study is available.
- Population details are unavailable.
Does Standard care with capillary blood glucose monitoring improve blood glucose?
Standard care with capillary blood glucose monitoring may improve Blood glucose.
ConsistencyScore™: Results are mixed and should be interpreted cautiously.
Ranked evidence signals
- 1
Blood glucose
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 1 study
Why this answer: This answer is cautious because the available studies report mixed findings.
Limitations
- Only one supporting study is available.
- Population details are unavailable.
Does Standard care with capillary blood glucose monitoring improve quality of life?
Current evidence does not show a clear benefit of Standard care with capillary blood glucose monitoring for Quality of life.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
- 1
Quality of life
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | neutral | ConsistencyScore™ Consistent | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Population details are unavailable.
Next steps
Continue your research
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Evidence topics
Follow the topics this study contributes to.
Explore in Evidence Explorer
Open broader Evidence Explorer views for this relationship.
Related research
Read related research summaries.
Sin anuncios. Sin rastreo.
Centrada en la evidencia, no en la publicidad.
Segura y privada
Tus datos siempre están protegidos.
Siempre al día
Se agregan nuevos estudios todos los días.
